SCHEMBL24689984

SCHEMBL24689984

Nc1cc(-c2nnn[nH]2)cc(Oc2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCAT2 O15382 1/20 0.42
▸ MAPK1 P28482 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ NUDT1 P36639 1/20 0.39
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ BTK Q06187 2/20 0.37
▸ CHEK2 O96017 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ HTT P42858 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ XDH P47989 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30019977 1.00 BCAT2 (0.42) BCAT2MAPK1TDP1NUDT1MEN1
SCHEMBL30020727 0.79 ALDH1A1 (0.36) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL24690176 0.79 ALDH1A1 (0.36) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL25350701 0.78 MAPK1 (0.53) BCAT2MAPK1TDP1NUDT1MEN1
SCHEMBL6502581 0.75 LTA4H (0.49) CHEK2NPC1RAB9A
SCHEMBL706418 0.74 DHODH (0.45) CHEK2MAOBNPC1RAB9A
SCHEMBL29151881 0.73 HPGD (0.32) MAPK1TDP1NUDT1MEN1KMT2A
SCHEMBL24689985 0.72 PTGDR (0.44) MAPK1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL14556361 0.69 NOX1 (0.40) CYP1A2
SCHEMBL17923129 0.68 BCAT2 (0.49) BCAT2MAPK1TDP1NUDT1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022224212-A1 GPR35 AGONIST COMPOUNDS HEPTARES THERAPEUTICS LIMITED (GB) 2022-10-27 — — WO disclosed
Send feedback